New study aims to predict deadly infections in blood cancer patients
NCT ID NCT07396571
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at blood cancer patients who carry drug-resistant bacteria in their gut. Researchers want to find out who is most likely to get a serious infection from these bacteria. They will collect rectal swabs and track patients for 90 days to build a prediction tool. The goal is to help doctors prevent infections in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Hospital Clínico Universitario de Salamanca
Salamanca, 37007, Spain
-
Hospital Regional Universitario de Málaga
Málaga, 29010, Spain
-
Hospital Universitario De Jerez
Jerez de la Frontera, Cádiz, 11407, Spain
-
Hospital Universitario Juan Ramón Jiménez
Huelva, 21005, Spain
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Hospital Universitario Nuestra Señora de Valme
Seville, 41014, Spain
-
Hospital Universitario Puerta del Mar
Cadiz, 11009, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Torrecárdenas
Almería, Andalusia, 04009, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital Universitario Virgen Macarena
Seville, 41009, Spain
-
Hospital Universitario Virgen de las Nieves Ruiz de Alda
Granada, 18014, Spain
-
Hospital Universitario Virgen del Rocío
Seville, 41013, Spain
-
Hospital Universitario de Vigo
Vigo, Galicia, 36310, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Can trained immune cells stop blood cancer relapse?
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?